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mouse models with MPO-ANCA production. BALB/c mice were
given intraperitoneal (i.p.) injection of PMA (50 ng at day 0 and
day 7) and oral administration of PTU (5 mg/day) for 2 weeks. In
this model, MPO-ANCA was produced by day 14 though an
obvious vasculitic phenotype was not observed. These mice were
divided into two groups, namely Group 1 with daily i.p. injection
of Cl-amidine (0.3 mg/200 ml/day) (n¼7) and Group 2 with daily
i.p. injection of PBS (200 ml/day) (n¼13). Two weeks later, serum
MPO-ANCA titers and amounts of peritoneal NETs were compared
between the 2 groups.
Results: In vitro NET formation induced by 20 nM PMA with or
without 20 mM PTU was inhibited signiﬁcantly by 200 mM Cl-
amidine. Serum MPO-ANCA titers of Group 1 mice (32.3  31.0 ng/
ml) were signiﬁcantly lower than those of Group 2 mice (132.1 
41.6 ng/ml). The amounts of peritoneal NETs in Group 1 mice was
signiﬁcantly smaller than those in Group 2 mice. These ﬁndings
suggested that the NET formation was inhibited signiﬁcantly by Cl-
amidine both in vitro and in vivo, and that the MPO- ANCA
production was also suppressed by Cl-amidine in vivo.
Conclusions: PAD4 inhibitor suppresses MPO-ANCA production
through inhibition of NET formation in mouse model so that it
could be a novel therapeutic modality for MPO-AAV in humans.
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Introduction: Recent research has implicated that inﬂammation may
be a key pathophysiological mechanism in diabetic nephropathy
(DN), although its pathogenesis is multifactorial. Intercellular
adhesion molecule 1 (ICAM-1) is an acute phase marker of inﬂam-
mation and the ICAM-1 gene is located on chromosome 19p13.2 and
resides a linkage region to diabetes and DN. To investigate whether
ICAM-1 has effects in the development of DN, we have recently
performed genetic and pathological studies of this molecule in
Swedish and Malaysian subjects with normal glucose tolerance
(NGT), diabetes and DN.
Methods: We genotyped six single nucleotide polymorphisms
(SNPs) in the ICAM-1 gene with TaqMan allelic discrimination. We
also determined plasma ICAM-1 levels with an enzyme-linked im-
mune-sorbent assay kit.
Results: We found that non-synonymous SNP rs5498 (K469E A/G)
was associated diabetes and DN and the G allele had a protective
effect. Particularly, we found a high heterozygous index of this
polymorphism presenting in both populations. The genotype dis-
tribution of this polymorphism was kept in Hardy-Weinberg
Equilibrium and no duplicon in the genomic sequence was found.
The ICAM-1 K469E(A/G) polymorphism resides in the 5th Ig-like
domain of ICAM-1 protein. This domain is essential for dimeriza-
tion, surface presentation and solubilisation of proteins of the
protein and subsequently plays a crucial role in the activity of
ICAM-1 protein in the interaction with LFA-1 and the adhesion of B
cells. Furthermore, we found the carriers with heterozygous ge-
notype had higher fasting glucose levels among newly diagnosed
type 2 diabetes patients compared with the subjects with wild orS8mutant homozygous genotype. Plasma ICAM-1 levels were
increased from the subjects with NGT, diabetes without DN to the
patients with DN. Among diabetic patients with DN, the carriers
with heterozygous genotype had higher plasma ICAM-1 levels
compared with other patients.
Conclusions: Our study provided evidence that ICAM-1 has effects
in the development of DN. The patients carrying with heterozygous
genotype of SNP rs5498 (K469E A/G) in the ICAM-1 gene have
higher risk susceptibility to DN. The combined approach with
genotyping this polymorphism and measuring plasma ICAM-1
levels may be useful for prediction of DN in translation medicine.
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Introduction: Acute tubular necrosis (ATN) is common in severe
acute kidney injury (AKI). Inﬁltrating neutrophils contribute to the
crescendo of renal inﬂammation and kidney injury (necroin-
ﬂammation), but how neutrophils contribute to ATN is not clear.
We hypothesized that inﬁltrating neutrophils release neutrophil
extracellular traps (NETs), which implies the release of cytotoxic
DAMPs like histones that accelerate ATN and AKI.
Methods: In vivo; Postischemic AKI was induced in wild type mice
by unilateral clamping of the renal pedicle for 35 minutes followed
by reperfusion for 6h or 72h. Formation of NETs was identiﬁed by
immunostaining using citrullinated histone 3 (CitH3) antibody.
Intravascular NETs were conﬁrmed by neutrophil elastase (NE)-
DNA complex ELISA in plasma. Renalcell death was evaluated in
kidney sections by Tunel staining and PicoGreen DNA assay of
plasma. To investigate the effect of NETs inhibition in bilateral IRI
(ischemic 35min, reperfusion 24h) group of mice were treated with
either PAD inhibitor (PADin) or neutrophil depletion and sacriﬁced
24h after reperfusion. In vitro; To investigate whether hypoxia can
directly induce NETs formation or indirectly via hypoxia-induced
tubular cell death, 1) human neutrophils were incubated in 1% or
20%O2 for 24h, 2) the media of tubular cell line (TC), which were
incubated in 1% or 20%O2 for 24h, and stimulated with neutro-
phils for 4h. Furthermore, PMA or histone- induced NETs were
treated by PADin, anti-histone antibody and heparin. Histone-
stimulated neutrophil media were applied to TC. NETs and TC
injury in vitro were evaluated by CitH3 staining/MPO-DNA com-
plex and LDH assay, respectively.
Results: IRI kidney showed increased positivity for CitH3 in areas
of tubular necrosis of the outer medulla. Plasma levels of the NE-
DNA complex were increased in a time-dependent manner as
compared to sham-operated mice. NET-induced renal cell death was
shown in terms of increased Tunel positive area in kidney and
plasma DNA 6h after reperfusion compared to the sham group.
Subsequently, NETs in plasma and kidney increased 15w24h after
reperfusion. In bilateral IRI, treatment with both PADin and
neutrophil depletion signiﬁcantly reduced the plasma levels of NE-
DNA complex and NETs area in kidney compared to the vehicle
group. Treatment further improved renal excretory function in
terms of reducing plasma creatinine levels. In vitro, the NET-Kidney International Reports (2016) 1, S1–S22
TRANSLATIONAL IMMUNOLOGY IN KIDNEY DISEASE, ISN NEXUS SYMPOSIUM 2016induction rate in 1%O2 was same as that in 20%O2. In contrast,
media from hypoxic TC kept at 1%O2 activated NET formation.
TC-derived histones dose-dependently induced NETosis, which
implies a further release of cytotoxic DAMPs that kills renal cells.
Histone-induced NET formation was signiﬁcantly inhibited by anti-
histone IgG or heparin. PMA-induced NET formation was inhibited
by PADin. Conversely, media of histone-induced NETs induced TC
death.
Conclusions: Our data indicate that inﬁltrating neutrophils un-
dergoes NETosis within the peritubular capillaries, a process that
drives ATN via release of cytotoxic DAMPs like histones.
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Introduction: Ischemia/reperfusion injury (IRI) profoundly impacts
graft survival following kidney transplantation. Epithelial injury is
one of the earliest histological alterations of IRI and is especially
observed in the corticomedullary junction. In this region oxygen
tension is lowest whereas epithelial cells are metabolically very
active. Therefore we hypothesized that urinary metabolomics could
be a tool for non-invasive assessment of IRI-induced changes.
Methods: Ischemia/reperfusion was induced in Lewis rats by uni-
lateral clamping the left renal artery for 45 minutes and removing
the contralateral kidney. Rats were treated with either control
antibody or a protective antibody directed against Mannan-binding
lectin (MBL). Groups of rats were sacriﬁced at 2, 5 and 24 h post I/R
and samples (serum, urine, tissue) were collected. Markers of renal
function (serum creatinine and BUN) and injury (tissue staining and
mRNA) were determined. Moreover, the urinary metabolic proﬁles
were analysed using a GC-MS platform.
Results: We demonstrate that this IRI model is characterized by
early epithelial injury and an increased expression of KIM-1,
NGAL, IL-6 and rise in serum creatinine. Importantly, already at
2 hours a strong reduction of GRP78 protein expression is
observed, speciﬁcally in the corticomedullary junction. Loss of
GRP78, a regulator of the ER-stress response, was accompanied by
induction of downstream mediators spliced-XBP1 and CHOP
expression. Inhibition of MBL in vivo protected tubular cells from
rapid loss of GRP78 expression and consequent tubular injury.
Exploratory data analysis of the urinary metabolic proﬁles showed
a dominant effect of time, but not of the protective treatment. The
use of PLS regression models in combination with all injury
markers as response variables, only revealed a signiﬁcant associa-
tion between metabolic changes in urine and tissue expression of
GRP78. Exploring the variable importance of projection values we
have identiﬁed a number of metabolites, including alpha- keto-
glutarate, aconitic acid, uric acid, hippuric acid and desaminotyr-
osine which were signiﬁcantly contributing to the model and were
affected by protective anti-MBL treatment.
Conclusions: In conclusion, we show that loss of GRP78 and in-
duction of the ER-stress response is a very early process in IRI,
speciﬁcally taking place in the corticomedullary junction. Using aKidney International Reports (2016) 1, S1–S22combination of statistical models and speciﬁc intervention we could
link the metabolic trajectory to the recovery process and show that
metabolomics is a valuable tool for the evaluation of IRI at cellular
and tissue level.
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Introduction: Plasmacytoid dendritic cells (pDC) have a pivotal role
in clearing viral infections, and can regulate tolerance or immunity
depending on their activation status. We have previously demon-
strated a strong inﬂux of pDC in the tubulointerstitium of human
renal allograft rejection biopsies. In experimental transplant
models, pDC were demonstrated to be activators of indirect allor-
eactivity, suggesting they should be able to take up donor antigens.
In this study, we investigated the capacity and requirements of
human pDC to ingest and present donor antigen.
Methods: Human pDC were isolated from buffy coats of healthy
individuals using negative selection. pDC were cultured overnight
in the presence or absence of conditioned medium (CM) of human
kidney proximal tubular epithelial cells (HK2), followed by CpG/
CMV activation. Phagocytosis of CFSE-labelled apoptotic HK2 cells
was determined using ﬂow cytometry. Alternatively, pDC were
primed and activated, after which the cytokine/chemokine pro-
duction, the expression of costimulatory molecules and the T cell
stimulatory capacity was assessed.
Results: In absence of any stimulus pDC were unable to ingest
apoptotic cells (AC) (mean 2%), which was only slightly increased
after activation using TLR9 ligand CpG (mean 15%), in consensus
with previous reports. However, priming pDC by CM of HK2 cells,
as well as primary tubular epithelial cells, and subsequent TLR9
ligation using CpG or cytomegalovirus (CMV), strongly induced the
capacity to ingest AC (mean 44%). Priming by CM led to phos-
phorylation of the key transcription factor Interferon Regulatory
Factor-7, in absence of IFN production. Importantly, upon priming
10-fold lower concentrations of CpG were required to get optimal
TLR9 activation. Consequently, activated primed pDC produced
vast amounts of IFN (mean 5,354 vs 475 pg/mL) and the chemokines
CCL4 and CXCL10. Moreover, priming increased pDC phenotypic
maturation (CD40/80/83/86 and CCR7) and TLR7/9 expression,
compared to non-primed pDC. As a functional consequence, primed
pDC induced a vigorous allogeneic T cell proliferation as compared
to their non-primed counterparts (mean 60% vs 4%), as well as
inducing a strong TH1 skewing (e.g. IFN mean 2,268 vs 60 pg/mL).
Using donor HLA antigen and a CD4 T cell clone with indirect
speciﬁcity, pDC were shown to be cells with efﬁcient indirect an-
tigen presentation capacity.
Conclusions: In conclusion, we show that factors produced by
renal epithelial cells enable the phagocytic capacity of pDC
following TLR9 ligation. Moreover, this tissue priming lowers the
TLR9 activation threshold by one order of magnitude. Subse-
quently, TLR9 ligation by CpG or CMV strongly enhances theirS9
